Implandata Ophthalmic Products is a medical device company offering a new technology for the treatment and management of glaucoma patients.
Implandata Ophthalmic Products is an early stage, privately-held, venture capital funded medical device company based in Hannover, Germany. Implandata Ophthalmic Products is a medical device company offering a new technology for the treatment and management of glaucoma patients. It identifies an underserved area in care of glaucoma patients, creating disruptive solutions for better and more efficient glaucoma therapy, to the benefit of glaucoma patients, families, and care givers by integrating innovative medical technology with information technology.IOP has developed a novel technology for 24 hour measurement of intraocular pressure, by which monitoring and therapy of glaucoma patients will be improved. This solution will allow a more efficient treatment and management of glaucoma patients.Implandata Ophthalmic Products was founded on 2010.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 14, 2018 | Series C | — | 1 | — | — | Detail |
Aug 30, 2012 | Series A | €1.60M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
NKB | — | Series C |
ERP Startfonds | — | Series A |